NCT06204198View on ClinicalTrials.gov

Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

September 1, 2024

Conditions

Aggressive Fibromatosis of Abdominal Wall (Disorder)

Interventions

OTHER

No intervention

No intervention

Trial Locations (1)

250000

RECRUITING

Shandong Provincial Hospital, Jinan

All Listed Sponsors

lead

Shandong Provincial Hospital

OTHER_GOV